Compare COR & AME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COR | AME |
|---|---|---|
| Founded | 2001 | 1930 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.9B | 58.2B |
| IPO Year | 2001 | 1998 |
| Metric | COR | AME |
|---|---|---|
| Price | $331.41 | $238.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 12 |
| Target Price | ★ $390.62 | $233.27 |
| AVG Volume (30 Days) | ★ 1.2M | 1.2M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.77% | 0.60% |
| EPS Growth | 5.71 | ★ 7.93 |
| EPS | ★ 15.21 | 3.51 |
| Revenue | ★ $321,332,819,000.00 | $7,401,116,000.00 |
| Revenue This Year | $8.89 | $8.86 |
| Revenue Next Year | $6.75 | $5.57 |
| P/E Ratio | ★ $22.12 | $66.61 |
| Revenue Growth | ★ 9.31 | 6.63 |
| 52 Week Low | $244.82 | $179.30 |
| 52 Week High | $377.54 | $261.16 |
| Indicator | COR | AME |
|---|---|---|
| Relative Strength Index (RSI) | 65.64 | 38.90 |
| Support Level | $331.73 | $231.94 |
| Resistance Level | $350.77 | $241.66 |
| Average True Range (ATR) | 6.19 | 4.97 |
| MACD | 1.01 | -1.98 |
| Stochastic Oscillator | 91.90 | 15.30 |
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns more than 40 autonomous industrial businesses operating across research, aerospace, energy, medical, and manufacturing. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets it operates in.